Taxotere in malignant pleural mesothelioma. A phase II clinical trial

Lung Cancer ◽

10.1016/s0169-5002(00)80058-6 ◽

2000 ◽

Vol 29 (1) ◽

pp. 19 ◽

Author(s):

D.A Vorobiof ◽

M.R Chasen ◽

R Abratt ◽

B Rapoport ◽

N Cronje ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma

Download Full-text

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

Lung Cancer ◽

10.1016/j.lungcan.2013.05.006 ◽

2013 ◽

Vol 81 (3) ◽

pp. 422-427 ◽

Author(s):

Anna K. Nowak ◽

Chris Brown ◽

Michael J. Millward ◽

Jenette Creaney ◽

Michael J. Byrne ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Second Line ◽

Vascular Disrupting Agent ◽

Second Line Chemotherapy ◽

Line Chemotherapy ◽

Vascular Disrupting

Download Full-text

Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318260dfb9 ◽

2012 ◽

Vol 7 (9) ◽

pp. 1466-1470 ◽

Author(s):

Dean A. Fennell ◽

Cliona McDowell ◽

Sara Busacca ◽

Glen Webb ◽

Brian Moulton ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Line Treatment ◽

Download Full-text

P-620 An update of pemetrexed (P) plus gemcitabine (G) asfront-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial

Lung Cancer ◽

10.1016/s0169-5002(05)81113-4 ◽

2005 ◽

Vol 49 ◽

pp. S282

Author(s):

P. Janne ◽

G. Simon ◽

C. Langer ◽

R. Taub ◽

A. Dowlati ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Line Chemotherapy

Download Full-text

A Multi-Center Phase II Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody Amatuximab in Combination with Chemotherapy for Frontline Therapy of Malignant Pleural Mesothelioma: Updated Clinical Outcomes and Correlative Studies

Annals of Oncology ◽

10.1016/s0923-7534(20)34090-4 ◽

2012 ◽

Vol 23 ◽

pp. ix493

Author(s):

M. Reck ◽

R. Hassan ◽

T. Jahan ◽

H.L. Kindler ◽

L. Bazhenova ◽

...

Keyword(s):

Clinical Trial ◽

Monoclonal Antibody ◽

Clinical Outcomes ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Frontline Therapy ◽

Correlative Studies

Download Full-text

An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7067 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7067-7067 ◽

Author(s):

P. A. Janne ◽

G. R. Simon ◽

C. J. Langer ◽

R. N. Taub ◽

A. Dowlati ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Malignant Pleural Mesothelioma ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma ◽

Line Chemotherapy

Download Full-text

Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-0804 ◽

2014 ◽

Vol 20 (23) ◽

pp. 5927-5936 ◽

Author(s):

Raffit Hassan ◽

Hedy L. Kindler ◽

Thierry Jahan ◽

Lyudmila Bazhenova ◽

Martin Reck ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Pleural Mesothelioma

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

A result of phase II clinical trial for the dermatomycosis of new antifungus external preparation KP-363 ( butenafine hydrochloride ) cream and liquid.

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.52.586 ◽

1990 ◽

Vol 52 (3) ◽

pp. 586-595 ◽

Author(s):

AKIRA OKAWARA

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

ORAL INTAKE OF PURIFIED AQUEOUS SOLUTION OF OAT ?-GLUCANS HAS NO EFFECT ON GASTRIC MUCOSA HISTOLOGICAL CHANGES IN PATIENTS WITH CHRONIC GASTRITIS: A PILOT PHASE II CLINICAL TRIAL

10.26226/morressier.57c5383cd462b80296c9c8fb ◽

2016 ◽

Author(s):

Rafal Filip

Keyword(s):

Clinical Trial ◽

Aqueous Solution ◽

Gastric Mucosa ◽

Phase Ii ◽

Chronic Gastritis ◽

Oral Intake ◽

Phase Ii Clinical Trial ◽

Pilot Phase ◽

Histological Changes

Download Full-text

Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran of Phase II Clinical Trial

Case Medical Research ◽

10.31525/ct1-nct04197323 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Lower Extremity ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text